Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379375678> ?p ?o ?g. }
- W4379375678 abstract "The assessment of resectability after neoadjuvant chemotherapy of hepatoblastoma is dependent on Post-Treatment EXTENT of Disease (POSTTEXT) staging and its annotation factors P (portal venous involvement) and V (hepatic venous/inferior vena cava [IVC] involvement), but MR performance in assessing them remains unclear.To assess the diagnostic performance of contrast-enhanced MR imaging for preoperative POSTTEXT staging and diagnosing vascular involvement in terms of annotation factors P and V in pediatric hepatoblastoma following neoadjuvant chemotherapy.Retrospective.Thirty-five consecutive patients (17 males, median age, 24 months; age range, 6-98 months) with proven hepatoblastoma underwent preoperative MR imaging following neoadjuvant chemotherapy.3.0 T; T2-weighted imaging (T2WI), T2WI with fat suppression, diffusion weighted imaging, radial stack-of-the-star/Cartesian 3D Dixon T1-weighted gradient echo imaging.Three radiologists independently assessed the POSTTEXT stages and annotation factors P and V based on the 2017 PRE/POSTTEXT system. The sensitivities and specificities were calculated for 1) diagnosing each POSTTEXT stage; 2) discrimination of stages III and IV (advanced) from those stages I and II (non-advanced) hepatoblastomas; and 3) annotation factors P and V. The combination of pathologic findings and surgical records served as the reference standard.Sensitivity, specificity, Fleiss kappa test.The sensitivity and specificity ranges for discriminating advanced from non-advanced hepatoblastomas were 73.3%-80.0% and 80.0%-90.0%, respectively. For annotation factor P, they were 66.7%-100.0% and 90.6%, respectively. For factor V, they were 75.0% and 67.7%-83.9%, respectively. There was excellent, substantial, and moderate agreement on POSTTEXT staging (Fleiss kappa = 0.82), factors P (Fleiss kappa = 0.64), and factors V (Fleiss kappa = 0.60), respectively.MR POSTTEXT provides reliable discrimination between advanced and non-advanced tumors, and MR has moderate to excellent specificity at identifying portal venous and hepatic venous/IVC involvement.3 TECHNICAL EFFICACY: Stage 3." @default.
- W4379375678 created "2023-06-06" @default.
- W4379375678 creator A5001950452 @default.
- W4379375678 creator A5006977019 @default.
- W4379375678 creator A5009604591 @default.
- W4379375678 creator A5010854803 @default.
- W4379375678 creator A5026070862 @default.
- W4379375678 creator A5040027560 @default.
- W4379375678 creator A5050787253 @default.
- W4379375678 creator A5060099123 @default.
- W4379375678 creator A5074838225 @default.
- W4379375678 creator A5075112918 @default.
- W4379375678 creator A5079009219 @default.
- W4379375678 creator A5085075008 @default.
- W4379375678 date "2023-06-05" @default.
- W4379375678 modified "2023-10-17" @default.
- W4379375678 title "Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of <scp>MR</scp> in Staging <scp>POSTTEXT</scp> and Vascular Involvement" @default.
- W4379375678 cites W1986371442 @default.
- W4379375678 cites W1999150319 @default.
- W4379375678 cites W2000793890 @default.
- W4379375678 cites W2024116037 @default.
- W4379375678 cites W2041918437 @default.
- W4379375678 cites W2086780755 @default.
- W4379375678 cites W2088305490 @default.
- W4379375678 cites W2089003291 @default.
- W4379375678 cites W2098562845 @default.
- W4379375678 cites W2142539701 @default.
- W4379375678 cites W2146720328 @default.
- W4379375678 cites W2160894166 @default.
- W4379375678 cites W2164777277 @default.
- W4379375678 cites W2326502969 @default.
- W4379375678 cites W2508509227 @default.
- W4379375678 cites W2511705945 @default.
- W4379375678 cites W2546782356 @default.
- W4379375678 cites W2549880782 @default.
- W4379375678 cites W2567425064 @default.
- W4379375678 cites W2754724862 @default.
- W4379375678 cites W2789341408 @default.
- W4379375678 cites W2808064594 @default.
- W4379375678 cites W2909381283 @default.
- W4379375678 cites W2988774868 @default.
- W4379375678 cites W3038420803 @default.
- W4379375678 cites W3147677534 @default.
- W4379375678 cites W3154494526 @default.
- W4379375678 cites W4211261658 @default.
- W4379375678 cites W4306671438 @default.
- W4379375678 cites W4307504130 @default.
- W4379375678 cites W4315628831 @default.
- W4379375678 doi "https://doi.org/10.1002/jmri.28848" @default.
- W4379375678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37272790" @default.
- W4379375678 hasPublicationYear "2023" @default.
- W4379375678 type Work @default.
- W4379375678 citedByCount "0" @default.
- W4379375678 crossrefType "journal-article" @default.
- W4379375678 hasAuthorship W4379375678A5001950452 @default.
- W4379375678 hasAuthorship W4379375678A5006977019 @default.
- W4379375678 hasAuthorship W4379375678A5009604591 @default.
- W4379375678 hasAuthorship W4379375678A5010854803 @default.
- W4379375678 hasAuthorship W4379375678A5026070862 @default.
- W4379375678 hasAuthorship W4379375678A5040027560 @default.
- W4379375678 hasAuthorship W4379375678A5050787253 @default.
- W4379375678 hasAuthorship W4379375678A5060099123 @default.
- W4379375678 hasAuthorship W4379375678A5074838225 @default.
- W4379375678 hasAuthorship W4379375678A5075112918 @default.
- W4379375678 hasAuthorship W4379375678A5079009219 @default.
- W4379375678 hasAuthorship W4379375678A5085075008 @default.
- W4379375678 hasConcept C121608353 @default.
- W4379375678 hasConcept C126322002 @default.
- W4379375678 hasConcept C126838900 @default.
- W4379375678 hasConcept C143409427 @default.
- W4379375678 hasConcept C146357865 @default.
- W4379375678 hasConcept C151730666 @default.
- W4379375678 hasConcept C2776304256 @default.
- W4379375678 hasConcept C2776694085 @default.
- W4379375678 hasConcept C2778292576 @default.
- W4379375678 hasConcept C2910216633 @default.
- W4379375678 hasConcept C2989005 @default.
- W4379375678 hasConcept C530470458 @default.
- W4379375678 hasConcept C71924100 @default.
- W4379375678 hasConcept C86803240 @default.
- W4379375678 hasConceptScore W4379375678C121608353 @default.
- W4379375678 hasConceptScore W4379375678C126322002 @default.
- W4379375678 hasConceptScore W4379375678C126838900 @default.
- W4379375678 hasConceptScore W4379375678C143409427 @default.
- W4379375678 hasConceptScore W4379375678C146357865 @default.
- W4379375678 hasConceptScore W4379375678C151730666 @default.
- W4379375678 hasConceptScore W4379375678C2776304256 @default.
- W4379375678 hasConceptScore W4379375678C2776694085 @default.
- W4379375678 hasConceptScore W4379375678C2778292576 @default.
- W4379375678 hasConceptScore W4379375678C2910216633 @default.
- W4379375678 hasConceptScore W4379375678C2989005 @default.
- W4379375678 hasConceptScore W4379375678C530470458 @default.
- W4379375678 hasConceptScore W4379375678C71924100 @default.
- W4379375678 hasConceptScore W4379375678C86803240 @default.
- W4379375678 hasLocation W43793756781 @default.
- W4379375678 hasLocation W43793756782 @default.
- W4379375678 hasOpenAccess W4379375678 @default.
- W4379375678 hasPrimaryLocation W43793756781 @default.
- W4379375678 hasRelatedWork W1990873465 @default.
- W4379375678 hasRelatedWork W1991734694 @default.